About Amster Microcell
Amster Microcell is a company based in India founded in 2018. It operates as a B2B. The company has 24 employees as of March 31, 2023. Amster Microcell offers products and services including Microcrystalline cellulose, Magnesium stearate, Croscarmellose sodium, and Sodium starch glycollate. Amster Microcell operates in a competitive market with competitors including Accent Microcell and NextGen Exsome, among others.
- Headquarter India
- Employees 24 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amster Microcell Private Limited
- Date of Incorporation 06 Mar, 2018
- Jurisdiction Kadi, Gujarat, India
-
Annual Revenue
$4.44 M (USD)27.2as on Mar 31, 2023
-
Net Profit
$83 K (USD)-28.28as on Mar 31, 2023
-
EBITDA
$582.4 K (USD)-6.96as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
24
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amster Microcell
Amster Microcell offers a comprehensive portfolio of products and services, including Microcrystalline cellulose, Magnesium stearate, Croscarmellose sodium, and Sodium starch glycollate.
Powder used for direct compression in pharmaceutical formulations
Lubricant enhancing tablet flow and compression properties
Disintegrant for improved drug dissolution in tablets
Binder and disintegrant in pharmaceutical manufacturing processes
Funding Insights of Amster Microcell
Detailed funding history for Amster Microcell
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amster Microcell
Investment portfolio details for Amster Microcell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amster Microcell
Detailed financials for Amster Microcell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amster Microcell Comparisons
Peer comparison for Amster Microcell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amster Microcell
Amster Microcell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accent Microcell and NextGen Exsome, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microcrystalline cellulose and excipients are manufactured by Accent Microcell.
|
|
| Locked | Locked | Locked |
Offers exosome engineering, analysis, and purification services for industrial sectors.
|
Detailed competitors of Amster Microcell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amster Microcell
Complete news archive for Amster Microcell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amster Microcell
Amster Microcell was founded in 2018.
Amster Microcell is headquartered in India.
As of Mar 31, 2023, the latest employee count at Amster Microcell is 24.
Annual revenue of Amster Microcell is $4.44M as on Mar 31, 2023.
Amster Microcell specializes in manufacturing high-quality excipients such as microcrystalline cellulose, magnesium stearate, and croscarmellose sodium for pharmaceutical applications. Based in Gujarat, India, they use advanced technology to ensure precision and reliability in production. The company serves global pharmaceutical companies, focusing on sustainable practices and quality certifications to meet industry standards, while expanding facilities for better outcomes.
Amster Microcell's top competitors include Accent Microcell and NextGen Exsome.
Amster Microcell offers Microcrystalline cellulose, Magnesium stearate, Croscarmellose sodium, and Sodium starch glycollate.